BioSpace News Archive

Verona Pharma plc, announces that senior management will participate in the following conferences in November 2022.

Evotec SE presents at its Capital Markets Day an update on how the Company is taking meaningful steps to transform biologics manufacturing to enable global access.

Bionomics Limited announced that it will participate in the following upcoming investor conferences in November.

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter ended September 30, 2022.

Lusaris Therapeutics, a biotechnology company advancing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological conditions, launched with a $60 million Series A financing.

G1 Therapeutics, Inc., a commercial-stage oncology company, provided a corporate and financial update for the third quarter ended September 30, 2022.

Sotera Health Company announced that Alex Dimitrief is joining the Company as Senior Vice President and General Counsel.

Plus Therapeutics, Inc. announced it will present data from two ongoing clinical trials evaluating the Company’s lead investigational targeted radiotherapeutic, rhenium obisbemeda, in recurrent glioblastoma, leptomeningeal metastases, as well as clinical trial plans for pediatric brain cancer at the 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology being held November 16-20, 2022 at the Tampa Convention Center in Tampa Bay, Florida.

Taysha Gene Therapies, Inc. announced that it will report its financial results for the third quarter ended September 30, 2022, and host a corporate update conference call and webcast on Tuesday, November 8, 2022, at 8:00 AM Eastern Time.

Cara Therapeutics, Inc. announced that members of its Executive Leadership Team will present at the following investor conferences.